Solid tumor polygene detection gene chip and preparation method and detection device thereof

A technology of gene chip and detection method, applied in the field of tumor detection, can solve the problems of long cycle, large sample consumption and high cost

Active Publication Date: 2019-10-29
裕策医疗器械江苏有限公司
View PDF17 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, most of the relevant products on the market are single-item detection. Taking the three indicators (TMB, MSI, and targeted therapy site mutations) as

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solid tumor polygene detection gene chip and preparation method and detection device thereof
  • Solid tumor polygene detection gene chip and preparation method and detection device thereof
  • Solid tumor polygene detection gene chip and preparation method and detection device thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0111] The technical solution of the present invention is compared with the Chinese invention patent titled "gene chip for detection of tumor mutation burden and its preparation method and device" and the application number is 2018107129399. The main differences include:

[0112] a) Delete the genes shown in Table 5 below. These genes have a low contribution to the calculation of tumor mutation burden and are not genes related to targeted drugs.

[0113] table 5

[0114]

[0115]

[0116] b) Add the genes shown in Table 6 below. These genes have a high contribution to the calculation of tumor mutation burden, which can improve the accuracy of tumor mutation burden calculation.

[0117] Table 6

[0118] APOBEC3A LOC101927322 PRKACA TIMM23B ARTN MAP4K3 PRKDC TMEFF1 ATP2C1 METTL21A PROC TOE1 BCL2L11 MFSD11 RAD17 TPM3 C11ORF65 MYCNOS RAD50 U2AF1L5 C1QTNF5 NBPF10 REEP5 UGT1A10 CD3EAP NBPF19 RHO...

Embodiment 1

[0135] In this example, custom probes were designed, covering the probe sequences of Tables 1 to 4 and 28 SNP site regions. The chip performance test results are shown in Table 7 below. It can be seen that the probe design is compatible with the common Illumina platform and MGI platform, and the coverage of the design area reaches more than 99%, which meets the normal use requirements.

[0136] Table 7

[0137] sample number Sequencing platform Capture efficiency (%) Coverage(%) DNR901971SLZAA01_3_2 MGI 37.195 99.829 DNR901971XYZAA01_2_3 MGI 42.099 99.792 DNR901979SLZAA01_3_2 MGI 32.582 99.868 DNR901979XYZAA01_2_3 MGI 40.51 99.838 DNR902340SLZAA01_2_1 MGI 49.45 99.789 DNR902340XYZAA01_2_1 MGI 39.764 99.764 DNR903896SLZAA01_3_2 MGI 38.427 99.857 DNR903896XYZAA01_2_3 MGI 56.814 99.76 DNR904698SLZAA01_2_1 MGI 42.357 99.755 DNR904698XYZAA01_2_1 MGI 40.17 99.792 DNR900409SL...

Embodiment 2

[0139] This example shows the information analysis method, including off-machine data processing, data filtering and quality control, sequence comparison and result quality control, somatic cell mutation detection and result filtering, mutation result annotation, MSI detection, tumor purity prediction, TMB prediction , TMB medication guidance and other links. The above-mentioned information analysis method runs on the bioinformatics analysis cluster through the automatic scheduling system, and outputs the analysis results stably and efficiently. Such as image 3 As shown, each information analysis link is introduced in detail as follows:

[0140]a) Off-machine data processing: The data generated by the sequencer is usually in a special format, which needs to be converted into a common fastq file format first. In addition, multiple samples will be mixed on one sequencing chip, and the data belonging to each sample needs to be split before analysis. This method can adapt to t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a solid tumor polygene detection gene chip and a preparation method and a detection device thereof. The solid tumor polygene detection gene chip comprises a probe sequence of agene area used for detecting tumor mutational load and targeted pharmacy related mutation sites shown in a list 1 and a probe sequence used for detecting unstable position sites of a microsatellite shown in a list 2. According to the solid tumor polygene detection gene chip, the gene area of the 859 tumor mutational loads and the targeted pharmacy related mutation sites and the 250 unstable sitesof the microsatellites, the gene areas can truly reflect a change trend of tumor mutational loads and a microsatellite unstable state of a human whole-genome, the areas cover common targeted pharmacyrelated mutation sites, and the solid tumor polygene detection gene chip can be simultaneously used for detecting various tumor molecular markers.

Description

technical field [0001] The present application relates to the field of tumor detection, in particular to a solid tumor multi-gene detection gene chip and its preparation method and detection device. Background technique [0002] Tumors are diseases caused by mutations in the genome. Tumor treatment includes surgery, radiotherapy, chemotherapy, molecular targeted therapy, immunotherapy and other means, among which targeted therapy and immunotherapy need to formulate corresponding treatment strategies according to the status of clinical molecular markers. [0003] The targeted therapy of tumor is to design corresponding therapeutic drugs for the identified carcinogenic sites at the cell molecular level, specifically select the carcinogenic sites to bind and act, and make the tumor cells specifically die. Targeted therapy drugs can be divided into targeted epidermal growth factor receptor (EGFR) blockers, monoclonal antibodies against certain cell markers, tyrosine kinase rece...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/6886C12Q1/6858
CPCC12Q1/6886C12Q1/6858C12Q2600/106C12Q2600/156C12Q2535/122C12Q2531/113C12Q2537/165Y02A90/10
Inventor 李淼陈超张毅红陈龙昀李暾但旭
Owner 裕策医疗器械江苏有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products